BioMarin Pharmaceutical Inc. is a company in the U.S. stock market and it is a holding in 115 U.S.-traded ETFs. BMRN has around 12.4M shares in the U.S. ETF market. The largest ETF holder of BMRN is the iShares Biotechnology ETF (IBB), with approximately 1.49M shares. Investors may also find of interest that the ETF with the largest allocation to BMRN stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.81%. On average, U.S. ETFs allocate 0.32% of BMRN to their portfolios.
Additionally, BMRN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BMRN as a holding is the Invesco RAFI Strategic US Small Company ETF (IUSS), with a return of 69.76%.